Chimpanzees drum with regular rhythm when they beat on tree trunks, a form of ancient communication
Chimpanzees drum with regular rhythm when they beat on tree trunks, a new study shows.
Chimpanzees and humans last shared a common ancestor around 6 million years ago. Scientists suspect this ancient ancestor must have been a drummer — using beats to communicate.
'Our ability to produce rhythm — and to use it in our social worlds — that seems to be something that predates humans being human,' said study co-author Cat Hobaiter, a University of St Andrews primatologist.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
an hour ago
- Medscape
Napping Patterns Tied to All-Cause Mortality Risk
SEATTLE — Timing, duration, and variability of daytime napping are associated with an increased risk for mortality in middle- to older-aged adults, new research showed. An analysis of UK Biobank data, which included more than 86,000 non-shift workers, showed that longer naps, greater variability in daytime napping duration, and higher percentages of naps around noon and in the early afternoon are associated with an increased risk for all-cause mortality. 'Our study fills a gap in knowledge by showing that it's not just whether someone naps but how long, how variable, and when they nap may be meaningful indicators of future health risk,' lead investigator Chenlu Gao, PhD, with the Division of Sleep Medicine, Harvard Medical School and Massachusetts General Hospital in Boston, told Medscape Medical News . 'However, it's important to emphasize that these are associations. Because the design of this study is observational, we cannot determine whether napping patterns cause higher mortality risk or simply reflect underlying health conditions,' Gao cautioned. The findings will be presented on June 11 at SLEEP 2025. An Early Indicator of Declining Health? 'While many studies have examined the links between sleep and mortality, they have largely focused on nighttime sleep, often overlooking daytime sleep. However, napping is an important component of the 24-hour sleep-wake cycle and may carry its own health implications,' Gao explained. For the study, the researchers examined whether actigraphy-measured objective daytime napping behaviors predict all-cause mortality in 86,565 non-shift workers. The cohort had a mean age of 63 years at baseline, and 57% were women. They were monitored by actigraphy for 7 days, and daytime napping was defined as sleep between 9 AM and 7 PM. Median nap duration was 0.40 h/d, with 34% of naps taken between 9 and 11 AM, 10% between 11 AM and 1 PM, 14% between 1 and 3 PM, 19% between 3 and 5 PM, and 22% between 5 and 7 PM. During a follow-up period of up to 11 years, 5189 (6.0%) participants died. Overall, as individuals aged, naps tended to become longer and more irregular, with timing shifting toward the afternoon. After adjusting for potential confounders, including demographics, BMI, smoking, alcohol use, and nighttime sleep duration, longer nap duration was associated with an increased risk for mortality (hazard ratio [HR], 1.20 for 1 SD; P < .0001). Greater intraindividual variability (HR, 1.14 for 1 SD; P < .0001) and a higher percentage of naps between 11 AM and 1 PM (HR, 1.07 for 1 SD; P = .0005) and between 1 and 3 PM (HR, 1.07 for 1 SD; P = .0002) were also associated with an increased risk for mortality. 'These findings highlight the potential importance of considering napping behaviors in risk stratification of mortality in middle- to older-aged adults,' the researchers noted in their abstract. 'Longer or more irregular naps may reflect poor nighttime sleep, circadian rhythm disruption, or underlying health conditions such as cardiovascular disease, metabolic disorders, depression, or early neurodegenerative changes. Our findings suggest that certain patterns of napping could serve as early indicators of declining health,' said Gao. However, the researchers did not specifically test these mechanisms in this study, and further research is needed to clarify the biological pathways underlying these associations, Gao cautioned. Ask About Napping Commenting on the research for Medscape Medical News , James A. Rowley, MD, professor of medicine and program director, Sleep Medicine Fellowship, Rush University Medical Center in Chicago, said the 'major take-home message is that if physicians ask about a patient's sleep habits, they should also be asking about napping, not just the nocturnal sleep period. In other words, physicians should be asking their patients, 'do you nap during the day?'' 'One cannot ignore daytime napping and an evaluation for the etiology of daytime napping is important,' said Rowley. Rowley noted that the key questions to consider include whether the patient is obtaining sufficient nocturnal sleep. Could an underlying sleep disorder — such as sleep apnea or restless legs syndrome — be contributing? Might another medical condition, such as chronic heart failure or chronic obstructive pulmonary disease, be disrupting nighttime sleep and prompting daytime napping?
Medscape
2 hours ago
- Medscape
Nonsurgical Options Show Modest Benefit in Chronic Back Pain
In people with nonspecific chronic low back pain, nonsurgical interventions like cognitive-behavioral therapy and mindfulness possibly showed small-to-moderate long-term benefits in reducing pain intensity and disability. However, the evidence was mostly of low-to-moderate certainty. METHODOLOGY: Researchers conducted a systematic review and meta-analysis of 75 randomized or cluster randomized controlled trials involving 15,395 participants aged 16 years or older (mean age, 45.7 years; median percentage of women, 61%) with chronic low back pain lasting at least 12 weeks. They assessed the effectiveness of nonsurgical interventions for chronic low back pain (including 91% trials on nonspecific chronic low back pain) with a focus on long-term (1-2 years) and very long-term (≥ 2 years) outcomes. Psychological, physical, and combination nonsurgical interventions, including cognitive-behavioral therapy, mindfulness, and multidisciplinary care, were assessed, with exercise being the most frequently assessed intervention. Interventions were compared with placebo or sham, adjuvant interventions, no intervention, or usual care. Pain intensity and disability were assessed using scales like the Numerical Pain Rating Scale and Oswestry Disability Index, respectively, along with other measures, and the certainty of evidence was assessed. TAKEAWAY: At long-term follow-up, small-to-moderate reductions in pain intensity and disability were possibly seen with cognitive-behavioral therapy (mean differences, -7.2 and -5.7, respectively) and mindfulness (mean differences, -10.0 and -9.3, respectively) in individuals with nonspecific chronic low back pain. The evidence was of moderate certainty. Goal setting and needling interventions probably resulted in small reductions in disability, with mean differences of -8.3 and -4.8, respectively. Multicomponent biopsychosocial care and behavioral therapy might have led to moderate and small reductions, respectively, in pain intensity in those with nonspecific chronic low back pain (mean differences, -10.2 and -7.4, respectively; low-certainty evidence). Multidisciplinary care could have led to small reductions in disability (mean difference, -8.3). At very long-term follow-up, multidisciplinary care may have led to a moderate reduction in pain intensity (mean difference, -10.1), whereas exercise may have resulted in a moderate decrease in disability (mean difference, -10.2) in those with nonspecific chronic low back pain. The evidence was mostly of low certainty. IN PRACTICE: 'Although we identified some interventions with long-term effects for people with chronic low back pain, the clinical importance of the effects is uncertain,' the study authors wrote. 'Greater attention is needed on developing and testing interventions with long-term effects for chronic low back pain.' SOURCE: The study was led by Hazel J. Jenkins, PhD, Macquarie University, Sydney, Australia. It was published online on May 28, 2025, in The Lancet Rheumatology . LIMITATIONS: The certainty of the evidence was reduced for most comparisons because of the quality of the studies and inconsistencies in the results. DISCLOSURES: The study reported receiving no specific funding. Some authors reported receiving grants, support for attending meetings, research fellowships, and serving as members of the executive board of the network and/or as members of associations outside the submitted work.
Bloomberg
3 hours ago
- Bloomberg
Astra's Early Test Fuels Hope for Cell Therapy Approach to Lupus
AstraZeneca Plc said a handful of patients with lupus went into remission after getting an experimental treatment, as the UK drugmaker plows billions into the growing area of cell therapy called CAR-T. The medicine, which Astra gained in the takeover of Gracell Biopharmaceuticals Inc., has only just entered clinical trials. But the tiny study, conducted in Shanghai, had a stark impact on ten young volunteers whose disease wasn't controlled by earlier treatment. Six of them no longer showed signs of having lupus nine months after the one-time infusion, according to early results.
